230 related articles for article (PubMed ID: 31545473)
1. The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients.
Zhang S; Yue W; Xie Y; Liu L; Li S; Dang W; Xin S; Yang L; Zhai X; Cao P; Lu J
Oncol Rep; 2019 Nov; 42(5):1767-1780. PubMed ID: 31545473
[TBL] [Abstract][Full Text] [Related]
2. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.
Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J
Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814
[TBL] [Abstract][Full Text] [Related]
5. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
Wu K; Zhang C; Zhang C; Dai D
Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
[TBL] [Abstract][Full Text] [Related]
6. Construction and Analysis of lncRNA-Mediated ceRNA Network in Nasopharyngeal Carcinoma Based on Weighted Correlation Network Analysis.
Zou Z; Liu S; Ha Y; Huang B
Biomed Res Int; 2020; 2020():1468980. PubMed ID: 33102573
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.
Zhou W; Chang A; Zhao H; Ye H; Li D; Zhuo X
Cancer Biomark; 2020; 27(4):533-539. PubMed ID: 32083569
[TBL] [Abstract][Full Text] [Related]
8. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
9. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
11. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
12. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
Tai J; Park J; Han M; Kim TH
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
[TBL] [Abstract][Full Text] [Related]
14. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
15. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation.
Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY
Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377
[TBL] [Abstract][Full Text] [Related]
18. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
Zhang JZ; Wu ZH; Cheng Q
Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
20. MYC and hsa‑miRNA‑423‑5p as biomarkers in nasopharyngeal carcinoma revealed by miRNA‑mRNA‑pathway network integrated analysis.
Tian H; Chen S; Zhang C; Li M; Zheng H
Mol Med Rep; 2017 Aug; 16(2):1039-1046. PubMed ID: 28586063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
